← Leaderboards
Shi-Long Lu
University Of Colorado Denver
$3,811,941
Attributed
$4,477,391
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $539.1K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,477,391 · 6
By mechanism
R01$1,844,624 · 1
UH3$933,692 · 1
R21$856,625 · 2
R56$474,275 · 1
UH2$368,175 · 1
Top collaborators
- Daniel N Frank5 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Devatha P. Nair$1,440,953
- Sana D Karam$9,495,305
- Kent E Hutchison$29,753,664
- Scott A Weed$3,997,953
- Laurel B Darragh$130,882
Others in their field
Top investigators on “Head And Neck Cancer”
- Walter John Curran · Thomas Jefferson University$111,090,486
- Norman Wolmark · Nsabp Foundation, Inc.$59,047,729
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$42,566,636
- Charles A Coltman · Southwest Oncology Group$36,988,659
- James J. Dignam · University Of Chicago$35,003,821
Research focus
Head And Neck CancerHead And Neck Squamous Cell CarcinomaOral CavityMalignant NeoplasmsIncidenceAffectMouse ModelClinical ApplicationTranslatingIn VitroTumorMolecularPathway InteractionsSalivaLaboratoriesCell LineTumor ProgressionPik3ca GeneIn VivoPublishingExperimental StudyResponseOutcome ForecastMouth Neoplasms
Grant awards (15)
Validation of a saliva test using methylated microRNAs for head and neck cancer recurrence$312,497
UH3 · FY2025 · CA · contact PI
Functional roles of the human microbiome and metabolome in oral cancer$195,000
R21 · FY2025 · DE
Validation of a saliva test using methylated microRNAs for head and neck cancer recurrence$305,067
UH3 · FY2024 · CA · contact PI
Functional roles of the human microbiome and metabolome in oral cancer$234,000
R21 · FY2024 · DE
Validation of a saliva test using methylated microRNAs for head and neck cancer recurrence$316,128
UH3 · FY2023 · CA · contact PI
Validation of a saliva test using methylated microRNAs for head and neck cancer recurrence$94,860
UH2 · FY2022 · CA · contact PI
Validation of a saliva test using methylated microRNAs for head and neck cancer recurrence$273,315
UH2 · FY2021 · CA · contact PI
Oral Microbiota and Toll-Like Receptor Pathways in Head and Neck Cancer$194,375
R21 · FY2021 · DE · contact PI
Oral Microbiota and Toll-Like Receptor Pathways in Head and Neck Cancer$233,250
R21 · FY2020 · DE · contact PI
Modulation of Tumor Microenvironment by Microbiome in Head and Neck Cancer$474,275
R56 · FY2019 · DE · contact PI
The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis$371,900
R01 · FY2015 · DE · contact PI
The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis$371,900
R01 · FY2014 · DE · contact PI
The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis$357,024
R01 · FY2013 · DE · contact PI
The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis$371,900
R01 · FY2012 · DE · contact PI
The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis$371,900
R01 · FY2011 · DE · contact PI